NCT03158077View on ClinicalTrials.gov

Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection

CompletedOBSERVATIONAL
Enrollment

467

Participants

Timeline

Start Date

November 15, 2016

Primary Completion Date

April 20, 2017

Study Completion Date

April 20, 2017

Conditions
HIV Infections
Trial Locations (14)

Unknown

Hospital de Alicante, Alicante

Hospital de Mataró, Mataró

Hospital Santa Lucia, Cartagena

Hopital Severo Ochoa, Madrid

Hospital 12 de octubre, Madrid

Hospital Fundación Jimenez Díaz, Madrid

Hospital Infanta Leonor, Madrid

Hospital La Princesa, Madrid

Hospital Prícipe de Asturias, Madrid

Hospital Ramón y cajal, Madrid

Hospital Univ. La Paz, Madrid

Complejo hospitalario de Toledo, Toledo

Hospital Rio Hortega, Valladolid

Hospital Miguel Servet, Zaragoza

All Listed Sponsors
lead

Fundacion SEIMC-GESIDA

OTHER

NCT03158077 - Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection | Biotech Hunter | Biotech Hunter